These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5499456)

  • 21. [Preparation of antihemophilic cryoprotein from dextran plasma residue following the isolation of leukocytes].
    Vlcková M; Vopatová M; Kselíková M
    Vnitr Lek; 1975 Sep; 21(9):904-10. PubMed ID: 1179657
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of dextran on factor VIII and thrombus stability in humans. Significance of varying infusion rates.
    Aberg M; Arfors KE; Bergentz SE
    Acta Chir Scand; 1977; 143(7-8):417-9. PubMed ID: 345704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic studies of antihemophilic factor (AHF, factor VIII). IV. Radioimmunoassay of AHF antigen.
    Hoyer LW
    J Lab Clin Med; 1972 Dec; 80(6):822-33. PubMed ID: 4634503
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.
    Bennett B; Forman WB; Ratnoff OD
    J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Purification of antihemophilic factor VIII (AHF)].
    SIMONETTI C; CASILLAS G; PAVLOVSKY A
    Hemostase; 1961; 1():57-61. PubMed ID: 13913161
    [No Abstract]   [Full Text] [Related]  

  • 27. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor VIII concentrate prepared from human plasma.
    Kim IS; Choi YW; Kang Y; Sung HM; Shin JS
    J Microbiol Biotechnol; 2008 May; 18(5):997-1003. PubMed ID: 18633304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PURIFICATION OF ANTIHEMOPHILIC FACTOR (FACTOR VIII) BY AMINO ACID PRECIPITATION.
    WAGNER BH; MCLESTER WD; SMITH M; BRINKHOUS KM
    Thromb Diath Haemorrh; 1964 Apr; 11():64-74. PubMed ID: 14167116
    [No Abstract]   [Full Text] [Related]  

  • 30. Purification of recombinant human B-domain-deleted factor VIII using anti-factor VIII monoclonal antibody selected by the surface plasmon resonance biosensor.
    Oh HK; Lee JM; Byun TH; Park SY; Kim YH
    Biotechnol Prog; 2001; 17(6):1119-27. PubMed ID: 11735450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cryoprecipitation and dextran precipitation in obtaining factor VIII concentrates: comparative protein chemical studies].
    Liebe S; Kubel M; Wegner H
    Z Gesamte Inn Med; 1974 Mar; 29(6):232-6. PubMed ID: 4409089
    [No Abstract]   [Full Text] [Related]  

  • 32. The preclinical characterization of Monoclate factor VIII:C, antihemophilic factor (human).
    Schreiber AB
    Semin Hematol; 1988 Apr; 25(2 Suppl 1):27-32. PubMed ID: 3133774
    [No Abstract]   [Full Text] [Related]  

  • 33. Monoclonal antibodies against human factor VIII molecular neutralize antihemophilic factor and ristocetin cofactor activities.
    Sola B; Avner P; Sultan Y; Jeanneau C; Maisonneuve P
    Proc Natl Acad Sci U S A; 1982 Jan; 79(1):183-7. PubMed ID: 6798569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human antihemophilic factor (AHF) purification: A comparison of two procedures.
    Hurt JP; Wagner RH; Brinkhous KM
    Thromb Diath Haemorrh; 1966 May; 15(3):327-37. PubMed ID: 5989021
    [No Abstract]   [Full Text] [Related]  

  • 35. The in vitro association of antihemophilic factor and von Willebrand factor.
    Zucker MB; Soberano ME; Johnson AJ; Fulton AJ; Kowalski S; Adler M
    Thromb Haemost; 1983 Feb; 49(1):37-41. PubMed ID: 6405497
    [No Abstract]   [Full Text] [Related]  

  • 36. Human factor VIII: purification from commercial factor VIII concentrate, characterization, identification and radiolabeling.
    Hamer RJ; Koedam JA; Beeser-Visser NH; Sixma JJ
    Biochim Biophys Acta; 1986 Oct; 873(3):356-66. PubMed ID: 3092864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and some chemical properties of human factor VIII (antihemophilic factor).
    Hershgold EJ; Davison AM; Janszen ME
    J Lab Clin Med; 1971 Feb; 77(2):185-205. PubMed ID: 4993260
    [No Abstract]   [Full Text] [Related]  

  • 38. Purification and properties of porcine platelet aggregating factor.
    Marcus DL; Johnson AJ; Finlay TH
    Biochim Biophys Acta; 1978 Nov; 537(1):44-61. PubMed ID: 718981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihemophilic factor activity isolated from kidneys of normal and hemophilic dogs.
    Barrow EM; Graham JB
    Am J Physiol; 1971 Apr; 220(4):1020-4. PubMed ID: 4101480
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of factor VIII-associated platelet aggregation by heparin and dextran sulfate, and its mechanism.
    Suzuki K; Nishioka J; Hashimoto S
    Biochim Biophys Acta; 1979 Jul; 585(3):416-26. PubMed ID: 486540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.